Why the study?
Does TAVR improve 30-day quality of life similarly in patients with low-flow aortic stenosis compared to normal flow aortic stenosis?
Does TAVR improve 30-day quality of life similarly in patients with low-flow aortic stenosis compared to normal flow aortic stenosis?
Answers are grounded in this paper and cite their sources.
TAVR provides similar 30-day quality of life improvements in low-flow and normal-flow aortic stenosis, though low-flow patients face higher heart failure rehospitalization risks.
Key Points Patients with classical and paradoxical low‐flow (PLF) aortic stenosis (AS) experience similar improvements in 30‐day quality of life (QoL) following transcatheter aortic valve replacement (TAVR) as compared to those with normal flow AS. Particular care should be taken in post‐TAVR management of patients with PLF AS due to a higher rate of rehospitalization for heart failure. Promoting larger studies with follow‐up strategies that take into account the initial echocardiographic AS phenotype may help in further improving post‐TAVR QoL and outcomes.
No takes yet. Share an insight, caveat, or question.
Aranzulla et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: